Cigna deal gets antitrust nod, positive sign for CVS/Aetna

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. LBRX
2. BMY
3. MRK
4. TRAX
5. AON
6. TMUS
7. PLTR
8. DMART:IN
9. SPY
10. LMT

Go back to Cigna deal gets antitrust nod, positive sign for CVS/Aetna

Piper Jaffray Reiterates Overweight on Cigna Corp. (CI) Following Acquisition Approval

September 18, 2018 7:13 AM EDT

Piper Jaffray analyst, Sarah James, reiterated an Overweight rating and $215.00 price target on CIGNA (NYSE: CI) following the company's announcement that they have received DOJ approval for the ESRX acquisition. The deal is expected to closed by the end of the year.... More